Tolerability
Showing 26 - 50 of >10,000
Hyperlipidemia Trial in Beijing (JS401, Placebo)
Recruiting
- Hyperlipidemia
- JS401
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 15, 2023
Healthy Subjects Trial in Shanghai (JYP0061, )
Completed
- Healthy Subjects
- JYP0061
- placebo
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 16, 2023
Aging Trial (Salvia haenkei 175mg, Salvia haenkei 350mg)
Not yet recruiting
- Aging
- Salvia haenkei 175mg
- Salvia haenkei 350mg
- (no location specified)
Jun 30, 2023
Healthy Volunteers Trial in Glendale (AZD1163, Placebo)
Not yet recruiting
- Healthy Volunteers
- AZD1163
- Placebo
-
Glendale, CaliforniaResearch Site
Oct 23, 2023
Healthy Participants Trial in Glendale (AZD2389, Placebo)
Not yet recruiting
- Healthy Participants
- AZD2389
- Placebo
-
Glendale, CaliforniaResearch Site
Nov 14, 2023
Safety and Tolerability Trial in Shanghai (JMKX003002 will be administered orally, Placebo in Cohorts 1 to 5, Placebo in 2
Recruiting
- Safety and Tolerability
- JMKX003002 will be administered orally
- +2 more
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Jun 15, 2023
Obesity Trial in Beijing (PB-718, Placebo)
Recruiting
- Obesity
- PB-718
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Nov 24, 2023
Celiac Disease, Coeliac Disease Trial (KAN-101, Placebo)
Not yet recruiting
- Celiac Disease
- Coeliac Disease
- KAN-101
- Placebo
- (no location specified)
Aug 14, 2023
Diffuse Hair Loss in Females Trial in Schenefeld (Pantovigar® vegan)
Completed
- Diffuse Hair Loss in Females
- Pantovigar® vegan
-
Schenefeld, GermanyproDerm
Jul 3, 2023
Healthy Volunteer Trial in Los Angeles (IRL201104, Placebo)
Recruiting
- Healthy Volunteer
- IRL201104
- Placebo
-
Los Angeles, CaliforniaRevolo Phase I site
Jun 19, 2023
Cough Trial in Jinan (HS-10383, HS-10383 Placebo)
Recruiting
- Cough
- HS-10383
- HS-10383 Placebo
-
Jinan, Shandong, ChinaShandong provincial qianfoshan hospital
Oct 19, 2023
Intensive Cardiac Rehabilitation: Tolerability and Effectiveness
Enrolling by invitation
- Cardiac Disease
- (no location specified)
Jan 30, 2023
Osteochondrodysplasia Trial in Parkville (SAR442501)
Recruiting
- Osteochondrodysplasia
-
Parkville, Victoria, AustraliaInvestigational Site Number: 0360001
Oct 10, 2023
Idiopathic Pulmonary Fibrosis Trial in Shanghai (SC1011, Placebo tablet)
Completed
- Idiopathic Pulmonary Fibrosis
- SC1011
- Placebo tablet
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 14, 2023
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Atopic Dermatitis Trial in Changsha (QLM3003, QLM3003 Placebo)
Recruiting
- Atopic Dermatitis
- QLM3003
- QLM3003 Placebo
-
Changsha, Hunan, ChinaThe Third Xiangya Hospital of Central South University
Jul 2, 2023
Thrombosis Trial in Perth (SRSD107, Placebo)
Not yet recruiting
- Thrombosis
- SRSD107
- Placebo
-
Perth, Other (Non U.s.), AustraliaLinear Clinical Research
Nov 2, 2023
Healthy Trial in Toronto (ABX1100 injection for IV infusion, Placebo injection for IV infusion)
Recruiting
- Healthy
- ABX1100 injection for IV infusion
- Placebo injection for IV infusion
-
Toronto, CanadaStudy Site
Oct 25, 2023
Contraception Trial in Móstoles (LVDS)
Recruiting
- Contraception
- LVDS
-
Móstoles, Madrid, SpainLR-301/
Aug 30, 2023
Intestinal Health Trial in Chapel Hill ("Humanized" galacto-oligosaccharides (hGOS), Galacto-oligosaccharides (GOS), Matching
Not yet recruiting
- Intestinal Health
- "Humanized" galacto-oligosaccharides (hGOS)
- +2 more
-
Chapel Hill, North CarolinaUNC-Chapel Hill
Sep 28, 2023
Duchenne Muscular Dystrophy Trial (Givinostat, Placebo)
Not yet recruiting
- Duchenne Muscular Dystrophy
- Givinostat
- Placebo
- (no location specified)
Jun 27, 2023